Current Neurovascular Research
Title:Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19
Volume: 17 Issue: 5
Author(s): Kenneth Maiese
Affiliation:
Export Options
About this article
Cite this article as:
Maiese Kenneth , Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19, Current Neurovascular Research 2020; 17 (5) . https://dx.doi.org/10.2174/1567202617666201203110008
DOI https://dx.doi.org/10.2174/1567202617666201203110008 |
Print ISSN 1567-2026 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5739 |
22
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Critical Appraisal of the Risk of Bias in Systematic Reviews and Metaanalyses
Pertaining to COVID-19
Coronaviruses Reinventing Electronic Health Records During COVID-19: Better Patient Data and Faster Research by Restructuring Electronic Health Record Systems
Current Women`s Health Reviews The Synergic Role of Environmental Contaminants in the Immunological Effects of Viral Diseases, Such as COVID-19
Coronaviruses Subject Index To Volume 12
Current Pharmaceutical Design Editorial (Thematic Issue: “Infectious Diseases in Asia-Pacific: Historical and Contemporary Perspectives”)
Infectious Disorders - Drug Targets The Bananins: New Anticorona-RNA-Viral Agents with Unique Structural Signature
Anti-Infective Agents in Medicinal Chemistry Medicinal Importance, Pharmacological Activities and Analytical Aspects of a Flavonoid Glycoside ‘Nicotiflorin’ in the Medicine
Drug Metabolism and Bioanalysis Letters COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review
Current Pharmaceutical Design A Note on Estimating the Case Fatality Ratio for Novel Corona Virus Disease (COVID-19)
Coronaviruses Antifibrotic Drugs for COVID-19: From Orphan Drugs to Blockbusters?
Current Respiratory Medicine Reviews The use of Pseudotyped Coronaviruses for the Screening of Entry Inhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV, and SARS-CoV-2 by Blocking Receptor-spike Interaction
Current Pharmaceutical Biotechnology Antiviral Activity of Natural and Synthetic Brassinosteroids
Current Medicinal Chemistry - Anti-Infective Agents Computational Models and Methods for Drug Target Prediction and Drug Repositioning
Combinatorial Chemistry & High Throughput Screening Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus
Current Pharmaceutical Design New Approaches to Drug-DNA Interactions Based on Graphical Representation and Numerical Characterization of DNA Sequences
Current Computer-Aided Drug Design Can Probiotics Cure Inflammatory Bowel Diseases?
Current Pharmaceutical Design Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multilayered High Throughput Virtual Screening Approach
Current Pharmaceutical Design Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools
Coronaviruses Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options
Coronaviruses Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report
Infectious Disorders - Drug Targets